Cantor Fitzgerald Initiates Coverage On LeMaitre Vascular with Neutral Rating, Announces Price Target of $96
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald has initiated coverage on LeMaitre Vascular with a Neutral rating and set a price target of $96.
October 15, 2024 | 11:23 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cantor Fitzgerald has initiated coverage on LeMaitre Vascular with a Neutral rating and a price target of $96, indicating a balanced view on the stock's potential.
The Neutral rating suggests that the analyst does not foresee significant upside or downside in the short term. The price target of $96 provides a benchmark for investors, but the neutral stance indicates a balanced view on the stock's potential.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100